BAYER AG

BAYER AG logo
πŸ‡©πŸ‡ͺGermany
Ownership
Public
Established
1863-08-01
Employees
99.7K
Market Cap
$30.1B
Website
http://www.bayer.com

Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma

Phase 2
Completed
Conditions
Interventions
First Posted Date
2002-09-04
Last Posted Date
2013-10-14
Lead Sponsor
Bayer
Target Recruit Count
29
Registration Number
NCT00044551

Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients

First Posted Date
2002-09-04
Last Posted Date
2014-12-23
Lead Sponsor
Bayer
Target Recruit Count
82
Registration Number
NCT00044525

A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma

First Posted Date
2002-09-04
Last Posted Date
2014-04-16
Lead Sponsor
Bayer
Target Recruit Count
137
Registration Number
NCT00044512

Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell Carcinoma

Phase 2
Completed
Conditions
Interventions
First Posted Date
2002-09-04
Last Posted Date
2014-12-19
Lead Sponsor
Bayer
Target Recruit Count
54
Registration Number
NCT00044564

Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen

Phase 3
Completed
Conditions
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Bayer
Registration Number
NCT00002238
Locations
πŸ‡ΊπŸ‡Έ

Alta Bates / Herrick Hosp, Berkeley, California, United States

πŸ‡ΊπŸ‡Έ

USC School of Medicine / Norris Cancer Hosp, Los Angeles, California, United States

πŸ‡ΊπŸ‡Έ

Cedars Sinai Med Ctr, Los Angeles, California, United States

and more 22 locations
Β© Copyright 2024. All Rights Reserved by MedPath